Immunic, Inc. (IMUX): Depreciation & Amortization
$168.0K
Year ended 2025-12-31
$149.0K
Trailing 12 months to 2026-06-30
+29.7%
3-year compound annual growth
+33.9%
5-year compound annual growth
-18.7%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $168.0K | +25.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $134.0K | +20.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $111.0K | +44.2% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $77.0K | -9.4% | 2024-02-22, From 2022-01-01 |
| 2021-12-31 | $85.0K | +117.9% | 2023-02-23, From 2021-01-01 |
| 2020-12-31 | $39.0K | -22.0% | 2022-02-24, From 2020-01-01 |
| 2019-12-31 | $50.0K | +233.3% | 2021-02-26, From 2019-01-01 |
| 2018-12-31 | $15.0K | -98.5% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $998.0K | -44.8% | 2019-03-04, From 2017-01-01 |
| 2016-12-31 | $1.81M | +36.1% | 2019-03-04, From 2016-01-01 |
| 2015-12-31 | $1.33M | +22.2% | 2018-03-13, From 2015-01-01 |
| 2014-12-31 | $1.09M | +36.0% | 2017-03-07, From 2014-01-01 |
| 2013-12-31 | $799.0K | +22.7% | 2016-03-08, From 2013-01-01 |
| 2012-12-31 | $651.0K | n/a | 2015-03-20, From 2012-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Immunic, Inc. (IMUX) | 2025-12-31 | $168.0K | +25.4% |
| Rein Therapeutics, Inc. (RNTX) | 2025-12-31 | $1.0K | -98.4% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $24.8K | +29.1% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.04M | -12.0% |
| Integrated Biopharma Inc (INBP) | 2025-06-30 | $318.0K | +3.6% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $15.2K | -97.9% |
| Faeth Therapeutics, Inc. (FTH) | 2025-12-31 | $122.0K | -77.9% |
| Gain Therapeutics, Inc. (GANX) | 2025-12-31 | $94.0K | +11.9% |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | $1.20M | -7.7% |
Compare IMUX, RNTX, KPRX, HCWB side by side · Screen every company in Pharmaceutical Preparations ↗